Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
Research ArticleOriginal Article

BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas

Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang and Rutong Yu
Cancer Biology & Medicine February 2021, 18 (1) 88-104; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0096
Shangfeng Gao
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhuang Sha
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Junbo Zhou
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yihao Wu
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yunnong Song
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cheng Li
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuejiao Liu
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tong Zhang
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tong Zhang
  • For correspondence: [email protected] [email protected]
Rutong Yu
1Institute of Nervous System Diseases, Xuzhou Medical University; Department of Neurosurgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou 221002, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rutong Yu
  • For correspondence: [email protected] [email protected]
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    1. Ohgaki H,
    2. Kleihues P.
    Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol. 2005; 64: 479–89.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Stupp R,
    2. Hegi ME,
    3. Mason WP,
    4. van den Bent MJ,
    5. Taphoorn MJ,
    6. Janzer RC, et al.
    Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10: 459–66.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Roos J,
    2. Luz JM,
    3. Centoducati S,
    4. Sternglanz R,
    5. Lennarz WJ.
    ENP1, an essential gene encoding a nuclear protein that is highly conserved from yeast to humans. Gene. 1997; 185: 137–46.
    OpenUrlCrossRefPubMedWeb of Science
  4. 4.↵
    1. Chen W,
    2. Bucaria J,
    3. Band DA,
    4. Sutton A,
    5. Sternglanz R.
    Enp1, a yeast protein associated with U3 and U14 snoRNAs, is required for pre-rRNA processing and 40S subunit synthesis. Nucleic Acids Res. 2003; 31: 690–9.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Stewart MJ,
    2. Nordquist EK.
    Drosophila Bys is nuclear and shows dynamic tissue-specific expression during development. Dev Genes Evol. 2005; 215: 97–102.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Wang H,
    2. Xiao W,
    3. Zhou Q,
    4. Chen Y,
    5. Yang S,
    6. Sheng J, et al.
    Bystin-like protein is upregulated in hepatocellular carcinoma and required for nucleologenesis in cancer cell proliferation. Cell Res. 2009; 19: 1150–64.
    OpenUrlCrossRefPubMedWeb of Science
  7. 7.↵
    1. Godoy H,
    2. Mhawech-Fauceglia P,
    3. Beck A,
    4. Miliotto A,
    5. Miller A,
    6. Lele S, et al.
    Developmentally restricted differentiation antigens are targets for immunotherapy in epithelial ovarian carcinoma. Int J Gynecol Pathol. 2013; 32: 536–40.
    OpenUrl
  8. 8.↵
    1. Ayala GE,
    2. Dai H,
    3. Li R,
    4. Ittmann M,
    5. Thompson TC,
    6. Rowley D, et al.
    Bystin in perineural invasion of prostate cancer. Prostate. 2006; 66: 266–72.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Azzato EM,
    2. Driver KE,
    3. Lesueur F,
    4. Shah M,
    5. Greenberg D,
    6. Easton DF, et al.
    Effects of common germline genetic variation in cell cycle control genes on breast cancer survival: results from a population-based cohort. Breast Cancer Res. 2008; 10: R47.
    OpenUrlCrossRefPubMed
  10. 10.↵
    1. Sheng J,
    2. Yang S,
    3. Xu L,
    4. Wu C,
    5. Wu X,
    6. Li A, et al.
    Bystin as a novel marker for reactive astrocytes in the adult rat brain following injury. Eur J Neurosci. 2004; 20: 873–84.
    OpenUrlCrossRefPubMed
  11. 11.↵
    1. Du F,
    2. Qian ZM,
    3. Zhu L,
    4. Wu XM,
    5. Qian C,
    6. Chan R, et al.
    Purity, cell viability, expression of GFAP and bystin in astrocytes cultured by different procedures. J Cell Biochem. 2010; 109: 30–7.
    OpenUrlPubMed
  12. 12.↵
    1. Wang X,
    2. Wang Z,
    3. Zhang Y,
    4. Wang Y,
    5. Zhang H,
    6. Xie S, et al.
    Golgi phosphoprotein 3 sensitizes the tumour suppression effect of gefitinib on gliomas. Cell Prolif. 2019; 52: e12636.
  13. 13.↵
    1. Zhang Y,
    2. Xie P,
    3. Wang X,
    4. Pan P,
    5. Wang Y,
    6. Zhang H, et al.
    YAP promotes migration and invasion of human glioma cells. J Mol Neurosci. 2018; 64: 262–72.
    OpenUrlCrossRef
  14. 14.↵
    1. Liu T,
    2. Deng M,
    3. Li J,
    4. Tong X,
    5. Wei Q,
    6. Ye X.
    Phosphorylation of right open reading frame 2 (Rio2) protein kinase by polo-like kinase 1 regulates mitotic progression. J Biol Chem. 2011; 286: 36352–60.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Tang Z,
    2. Li C,
    3. Kang B,
    4. Gao G,
    5. Li C,
    6. Zhang Z.
    GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017; 45: W98–W102.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Zhang T,
    2. Ji D,
    3. Wang P,
    4. Liang D,
    5. Jin L,
    6. Shi H, et al.
    The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway. Cancer Lett. 2018; 415: 151–63.
    OpenUrl
  17. 17.↵
    1. Gao SF,
    2. Qi XR,
    3. Zhao J,
    4. Balesar R,
    5. Bao AM,
    6. Swaab DF.
    Decreased NOS1 expression in the anterior cingulate cortex in depression. Cereb Cortex. 2013; 23: 2956–64.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Gao S,
    2. Zhang T,
    3. Jin L,
    4. Liang D,
    5. Fan G,
    6. Song Y, et al.
    CAPON is a critical protein in synaptic molecular networks in the prefrontal cortex of mood disorder patients and contributes to depression-like behavior in a mouse model. Cereb Cortex. 2019; 29: 3752–65.
    OpenUrl
  19. 19.↵
    1. Zhou X,
    2. Hua L,
    3. Zhang W,
    4. Zhu M,
    5. Shi Q,
    6. Li F, et al.
    FRK controls migration and invasion of human glioma cells by regulating JNK/c-Jun signaling. J Neurooncol. 2012; 110: 9–19.
    OpenUrlCrossRefPubMed
  20. 20.↵
    1. Hou P,
    2. Li L,
    3. Chen F,
    4. Chen Y,
    5. Liu H,
    6. Li J, et al.
    PTBP3-mediated regulation of ZEB1 mRNA stability promotes epithelial-mesenchymal transition in breast cancer. Cancer Res. 2018; 78: 387–98.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Lan Y,
    2. Lou J,
    3. Hu J,
    4. Yu Z,
    5. Lyu W,
    6. Zhang B.
    Downregulation of SNRPG induces cell cycle arrest and sensitizes human glioblastoma cells to temozolomide by targeting Myc through a p53-dependent signaling pathway. Cancer Biol Med. 2020; 17: 112–31.
    OpenUrl
  22. 22.↵
    1. Wang T,
    2. Chen J,
    3. Tang CX,
    4. Zhou XY,
    5. Gao DS.
    Inverse expression levels of EphrinA3 and EphrinA5 contribute to dopaminergic differentiation of human SH-SY5Y cells. J Mol Neurosci. 2016; 59: 483–92.
    OpenUrl
  23. 23.↵
    1. Liu X,
    2. Chong Y,
    3. Tu Y,
    4. Liu N,
    5. Yue C,
    6. Qi Z, et al.
    CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways. J Hematol Oncol. 2016; 9: 108.
    OpenUrl
  24. 24.↵
    1. Morris G,
    2. Walker AJ,
    3. Berk M,
    4. Maes M,
    5. Puri BK.
    Cell death pathways: a novel therapeutic approach for neuroscientists. Mol Neurobiol. 2018; 55: 5767–86.
    OpenUrlCrossRef
  25. 25.↵
    1. Read RD,
    2. Fenton TR,
    3. Gomez GG,
    4. Wykosky J,
    5. Vandenberg SR,
    6. Babic I, et al.
    A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma. PLoS Genet. 2013; 9: e1003253.
  26. 26.↵
    1. Liu K,
    2. Chen HL,
    3. Wang S,
    4. Gu MM,
    5. Chen XM,
    6. Zhang SL, et al.
    High expression of RIOK2 and NOB1 predict human non-small cell lung cancer outcomes. Sci Rep. 2016; 6: 28666.
    OpenUrl
  27. 27.↵
    1. Adachi K,
    2. Soeta-Saneyoshi C,
    3. Sagara H,
    4. Iwakura Y.
    Crucial role of Bysl in mammalian preimplantation development as an integral factor for 40S ribosome biogenesis. Mol Cell Biol. 2007; 27: 2202–14.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    1. Geerlings TH,
    2. Faber AW,
    3. Bister MD,
    4. Vos JC,
    5. Raue HA.
    Rio2p, an evolutionarily conserved, low abundant protein kinase essential for processing of 20S Pre-rRNA in Saccharomyces cerevisiae. J Biol Chem. 2003; 278: 22537–45.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    1. Hannan KM,
    2. Sanij E,
    3. Hein N,
    4. Hannan RD,
    5. Pearson RB.
    Signaling to the ribosome in cancer--It is more than just mTORC1. IUBMB Life. 2011; 63: 79–85.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. Brennan CW,
    2. Verhaak RG,
    3. McKenna A,
    4. Campos B,
    5. Noushmehr H,
    6. Salama SR, et al.
    The somatic genomic landscape of glioblastoma. Cell. 2013; 155: 462–77.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

Cancer Biology and Medicine: 18 (1)
Cancer Biology & Medicine
Vol. 18, Issue 1
1 Feb 2021
  • Table of Contents
  • Index by author
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on Cancer Biology & Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
(Your Name) has sent you a message from Cancer Biology & Medicine
(Your Name) thought you would like to see the Cancer Biology & Medicine web site.
Citation Tools
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang, Rutong Yu
Cancer Biology & Medicine Feb 2021, 18 (1) 88-104; DOI: 10.20892/j.issn.2095-3941.2020.0096

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
Shangfeng Gao, Zhuang Sha, Junbo Zhou, Yihao Wu, Yunnong Song, Cheng Li, Xuejiao Liu, Tong Zhang, Rutong Yu
Cancer Biology & Medicine Feb 2021, 18 (1) 88-104; DOI: 10.20892/j.issn.2095-3941.2020.0096
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Material and methods
    • Results
    • Discussion
    • Conclusions
    • Grant support
    • Supporting Information
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer
  • Genetic polymorphisms in genes regulating cell death and prognosis of patients with rectal cancer receiving postoperative chemoradiotherapy
  • Combined chemo-endocrine therapy as a potential new option for HR+/HER2− advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine
Show more Original Article

Similar Articles

Subjects

  • Brain Tumor

Keywords

  • Bystin
  • glioblastoma
  • proliferation
  • apoptosis
  • AKT

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire